🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.
UPGRADE TO SEE LIVE SIGNALS
$EVLO
Evelo Biosciences Inc
FREE PREVIEW
AVG HISTORICAL GAP2.00%
MAX GAP RECORD7.27%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY3.1%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Foxborough, MA. Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL